Capital International Investors Portfolio holdings
Capital International, established in 1968 as a division of the Los Angeles-based Capital Group, is a global investment management firm focused on delivering equity investment solutions for institutional and individual clients worldwide. Operating as part of one of the oldest and largest asset managers, founded in 1931, it leverages Capital Group’s signature research-driven, long-term investment philosophy, managing billions in assets through a multi-manager system that diversifies risk and enhances performance. Headquartered in Los Angeles with a presence across North America, Europe, and Asia, Capital International specializes in international and global equity strategies, often through mutual funds like those in the American Funds family. Known for its rigorous fundamental analysis and commitment to client outcomes, it plays a key role in Capital Group’s mission to provide consistent, superior returns in global markets.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NLSN
Nielsen Holdings plc
NLSN
|
+$360M |
| 2 |
Medtronic
MDT
|
+$289M |
| 3 |
Invesco
IVZ
|
+$230M |
| 4 |
Eli Lilly
LLY
|
+$221M |
| 5 |
Procter & Gamble
PG
|
+$214M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$779M |
| 2 |
Merck
MRK
|
+$244M |
| 3 |
KRFT
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
|
+$211M |
| 4 |
RCPT
RECEPTOS INC COM STK (DE)
RCPT
|
+$196M |
| 5 |
VRN
Veren
VRN
|
+$194M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 13.99% |
| 2 | Healthcare | 13.28% |
| 3 | Industrials | 11.21% |
| 4 | Technology | 10.19% |
| 5 | Consumer Staples | 9.87% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
251
Weyerhaeuser
WY
$17.8B
| $7K | ﹤0.01% |
+251
| New | +$7.41K |
|
|
WBA
252
DELISTED
Walgreens Boots Alliance
WBA
| $6K | ﹤0.01% |
+77
| New | +$6.96K |
|
253
Biogen
BIIB
$30.9B
| – | – |
-24
| Closed | -$10K |
|
254
Dominion Energy
D
$59.8B
| – | – |
-600,000
| Closed | -$40.1M |
|
255
Regeneron Pharmaceuticals
REGN
$82.2B
| – | – |
-36
| Closed | -$18K |
|
256
Vale
VALE
$61.4B
| – | – |
-1,500,300
| Closed | -$8.84M |
|
257
Vertex Pharmaceuticals
VRTX
$133B
| – | – |
-111
| Closed | -$14K |
|
|
VRN
258
DELISTED
Veren
VRN
| – | – |
-9,557,960
| Closed | -$194M |
|
|
RCPT
259
DELISTED
RECEPTOS INC COM STK (DE)
RCPT
| – | – |
-1,032,629
| Closed | -$196M |
|
|
PPO
260
DELISTED
POLYPORE INTERNATIONAL, INC
PPO
| – | – |
-700,000
| Closed | -$41.9M |
|
|
KRFT
261
DELISTED
KRAFT FOODS GROUP INC COM STK (VA)
KRFT
| – | – |
-2,479,668
| Closed | -$211M |
|
Similar funds
Capital International Investors's Q3 2015 Portfolio in Review
As of Q3 2015, Capital International Investors held 276 positions worth $55.1B, down 6.6% from $59B the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Capital International Investors's Q3 2015 filing shows 17 new, 102 increased, 40 reduced and 10 closed positions. Its largest new stake was Nielsen Holdings plc: 7,793,212 shares worth $347M. The largest sale was Bristol-Myers Squibb, an estimated $779M.
By sector, the portfolio is most concentrated in Financials at 14% of assets, up from 14% a quarter earlier, followed by Healthcare and Industrials.
- Capital International Investors's largest Q3 2015 buy was Nielsen Holdings plc: 7,793,212 shares worth $347M.
- Capital International Investors added most to Medtronic in Q3 2015, an estimated $289M increase.
- Capital International Investors's biggest Q3 2015 reduction was Bristol-Myers Squibb, cutting an estimated $779M.
- Capital International Investors fully exited KRAFT FOODS GROUP INC COM STK (VA) in Q3 2015, selling an estimated $211M.
- Capital International Investors's ten largest holdings make up 21% of its $55.1B portfolio in Q3 2015.
- Capital International Investors opened 17 new positions and closed 10 in Q3 2015.
- Capital International Investors's portfolio value fell 6.6% quarter-over-quarter to $55.1B.
Based on Capital International Investors's 13F filing for Q3 2015, filed 16 Nov 2015.